G. Broggini et al. / Tetrahedron: Asymmetry 18 (2007) 1495–1501
1499
4.6.1. (aR,3aR,9bR)-5-Carbethoxy-1-(1-phenyl-2-hydroxy-
ethyl)-7,8,9-trimethoxy-1,3a,4,9b-tetrahydro-3H-isoxazolo-
[4,3-c]quinoline 8a. IR (Nujol): 3478, 1701 cmꢀ1. Mp 49–
4.6.4. (aR,3aS,9bS)-5-Carbethoxy-1-(1-phenyl-2-hydroxy-
ethyl)-7-methoxy-8-methyl-1,3a,4,9b-tetrahydro-3H-isoxaz-
olo[4,3-c]quinoline 9b. IR (Nujol): 3472, 1700 cmꢀ1. Mp
23
23
1
51 ꢁC (diisopropyl ether). ½aꢁD ¼ ꢀ19:5 (c 0.7, CHCl3). H
NMR (400 MHz, CDCl3) d: 1.30 (3H, t, J = 7.1 Hz), 2.09
(1H, br s, missing after deuteriation), 2.89–2.95 (1H, m),
3.06 (1H, dd, J = 3.3, 13.4 Hz), 3.65 (1H, dd, J = 1.7,
8.5 Hz), 3.76 (1H, dd, J = 7.2, 8.2 Hz), 3.86 (3H, s), 3.92
(3H, s), 3.96 (3H, s), 4.01–4.08 (3H, overlapping), 4.19
(1H, dd, J = 7.1, 17.8 Hz), 4.30 (1H, dd, J = 7.1,
17.8 Hz), 4.32 (1H, dd, J = 7.8, 13.4 Hz), 4.51 (1H, d,
J = 9.3 Hz), 6.91 (1H, s), 7.33–7.38 (3H, overlapping),
7.52–7.55 (2H, overlapping); 13C NMR (100 MHz, CDCl3)
d: 14.9 (q), 44.3 (d), 46.4 (t), 56.3 (q), 57.4 (d), 61.3 (q), 61.5
(q), 62.5 (t), 64.5 (t), 68.6 (d), 69.6 (t), 104.9 (d), 115.8 (s)
128.3 (d), 128.4 (d), 130.5 (d), 136.8 (s), 137.1 (s), 139.5
(s), 152.5 (s), 153.1 (s), 156.9 (s). MS: m/z 458 (M+). Anal.
Calcd for C24H30N2O7: C, 62.87; H, 6.59; N, 6.11. Found:
C, 63.13; H, 6.30; N, 6.22.
172–174 ꢁC (diisopropyl ether). ½aꢁD ¼ ꢀ9:3 (c 0.8, CHCl3).
1H NMR (400 MHz, 50 ꢁC, CDCl3) d: 1.32 (3H, t,
J = 7.1 Hz), 2.25 (3H, s), 2.55 (1H, br s, missing after deu-
teriation), 2.88–2.92 (1H, m), 3.19 (1H, dd, J = 4.9,
13.5 Hz), 3.63 (1H, ddd, J = 4.7, 9.2, 9.9 Hz), 3.82 (1H,
d, J = 8.3 Hz), 3.85 (3H, s), 3.91 (1H, d, J = 8.7 Hz), 3.93
(1H, dd, J = 4.7, 9.3 Hz), 4.05 (1H, dd, J = 9.3, 9.9 Hz),
4.12 (1H, d, J = 8.3 Hz), 4.17 (1H, dd, J = 2.5, 13.5 Hz),
4.25 (1H, dq, J = 7.1, 10.7 Hz), 4.33 (1H, dq, J = 7.1,
10.7 Hz), 6.94 (1H, s), 7.06 (1H, s), 7.36–7.42 (3H, overlap-
ping), 7.46–7.49 (2H, overlapping); 13C NMR (100 MHz,
CDCl3) d: 15.0 (q), 16.4 (q), 45.8 (d), 46.9 (t), 55.8 (q),
60.6 (d), 62.4 (t), 64.1 (t), 67.3 (d), 70.1 (t), 107.7 (d),
120.2 (s), 124.0 (s) 128.5 (d), 128.7 (d), 130.8 (d), 131.8
(d), 136.0 (s), 139.9 (s), 155.5 (s), 157.7 (s). MS: m/z 412
(M+). Anal. Calcd for C23H28N2O5: C, 66.97; H, 6.84; N,
6.79. Found: C, 67.13; H, 6.55; N, 6.99.
4.6.2. (aR,3aS,9bS)-5-Carbethoxy-1-(1-phenyl-2-hydroxy-
ethyl)-7,8,9-trimethoxy-1,3a,4,9b-tetrahydro-3H-isoxazolo-
[4,3-c]quinoline 9a. IR (Nujol): 3489, 1702 cmꢀ1. Mp 46–
Entry c: Elution with AcOEt/light petroleum (1:2) gave 9c
(14%) and 8c (72%).
23
1
48 ꢁC (diisopropyl ether). ½aꢁD ¼ ꢀ63:5 (c 1.0, CHCl3). H
NMR (400 MHz, CDCl3) d: 1.34 (3H, t, J = 7.1 Hz), 3.01
(1H, br s, missing after deuteriation), 3.06 (1H, dd, J =
2.2, 13.3 Hz), 3.23–2.26 (1H, m), 3.44 (3H, s), 3.74 (3H,
s), 3.76–3.82 (4H, overlapping), 3.99 (1H, dd, J = 5.4,
8.4 Hz), 4.04 (1H, dd, J = 3.2, 6.7 Hz), 4.09–4.14 (1H,
m), 4.23 (1H, dd, J = 7.1, 10.6 Hz), 4.34 (1H, dd, J = 7.1,
10.6 Hz), 4.41–4.49 (3H, overlapping), 6.84 (1H, s), 7.28–
7.33 (3H, overlapping), 7.37–7.40 (2H, overlapping); 13C
NMR (100 MHz, CDCl3) d: 14.9 (q), 43.4 (d), 46.7 (t),
56.3 (q), 60.0 (d), 60.4 (q), 61.1 (q), 62.5 (t), 67.2 (t), 69.4
(d), 69.6 (t), 103.9 (d), 115.7 (s), 128.1 (d), 128.5 (d),
129.4 (d), 136.7 (s), 138.3 (s), 139.0 (s), 152.5 (s), 152.9
(s), 155.7 (s). MS: m/z 458 (M+). Anal. Calcd for
C24H30N2O7: C, 62.87; H, 6.59; N, 6.11. Found: C, 62.79;
H, 5.91; N, 6.38.
4.6.5. (aR,3aR,10bR)-5-Carbethoxy-1-(1-phenyl-2-hydroxy-
ethyl)-1,3a,4,10b-tetrahydro-3H,8H-[1,3]dioxolo[4,5-g]isox-
azolo[4,3-c]quinoline 8c. IR (Nujol): 3492, 1705 cmꢀ1. Mp
23
198–200 ꢁC. ½aꢁD ¼ ꢀ7:9 (c 1.0, CHCl3). 1H NMR
(400 MHz, CDCl3) d: 1.31 (3H, t, J = 7.0 Hz), 2.95 (1H,
br s, missing after deuteriation), 3.34–3.39 (1H, m), 3.48
(1H, dd, J = 3.6, 13.4 Hz), 3.78 (1H, d, J = 6.7, Hz), 3.95
(1H, dd, J = 4.8, 8.5 Hz), 4.03 (1H, dd, J = 3.5, 6.7 Hz),
4.13–4.17 (2H, overlapping), 4.25 (2H, q, J = 7.0 Hz),
4.49 (1H, dd, J = 8.3, 8.5 Hz), 4.56 (1H, dd, J = 8.3,
8.5 Hz), 5.89 (2H, s), 6.42 (1H, s), 6.94 (1H, s), 7.35–7.43
(5H, overlapping); 13C NMR (100 MHz, CDCl3) d: 14.9
(q), 42.7 (d), 46.4 (t), 62.5 (t), 64.1 (d), 67.9 (t), 69.5 (d),
69.7 (t), 101.5 (t), 105.3 (d), 108.7 (d), 123.0 (s) 128.9 (d),
129.0 (d), 129.4 (d), 133.9 (s), 138.7 (s), 145.0 (s) 146.9
(s), 155.1 (s). MS: m/z 412 (M+). Anal. Calcd for
C22H24N2O6: C, 64.07; H, 5.87; N, 6.79. Found: C, 64.30;
H, 5.61; N, 6.55.
Entry b: Elution with AcOEt/light petroleum (1:1) gave 9b
(12%) and 8b (74%).
4.6.3. (aR,3aR,9bR)-5-Carbethoxy-1-(1-phenyl-2-hydroxy-
ethyl)-7-methoxy-8-methyl-1,3a,4,9b-tetrahydro-3H-isoxaz-
4.6.6. (aR,3aS,10bS)-5-Carbethoxy-1-(1-phenyl-2-hydroxy-
ethyl)-1,3a,4,10b-tetrahydro-3H,8H-[1,3]dioxolo[4,5-g]isox-
olo[4,3-c]quinoline 8b. IR (Nujol): 3481, 1701 cmꢀ1. Mp
azolo[4,3-c]quinoline 9c. IR (Nujol): 3475, 1705 cmꢀ1. Mp
23
23
56–58 ꢁC (diisopropyl ether). ½aꢁD ¼ ꢀ11:1 (c 0.9, CHCl3).
136–138 ꢁC (diisopropyl ether). ½aꢁD ¼ ꢀ7:4 (c 1.1, CHCl3).
1H NMR (400 MHz, CDCl3) d: 1.33 (3H, t, J = 7.1 Hz),
2.07 (3H, s), 3.04 (1H, br s, missing after deuteriation),
3.31–3.38 (1H, m), 3.43 (1H, dd, J = 3.5, 13.4 Hz), 3.77–
3.80 (4H, overlapping), 3.98 (1H, dd, J = 4.9, 8.5 Hz),
4.05 (1H, dd, J = 3.2, 6.9 Hz), 4.14–4.18 (2H, overlapping),
4.23–4.30 (3H, overlapping), 4.48 (1H, dd, J = 8.4, 8.5 Hz),
6.67 (1H, s), 7.02 (1H, s), 7.36–7.45 (5H, overlapping);
13C NMR (100 MHz, CDCl3) d: 14.9 (q), 16.2 (q), 42.5
(d), 46.1 (t), 55.8 (q), 62.4 (t), 63.6 (d), 68.0 (t), 69.5 (t),
69.7 (d), 106.0 (d), 120.9 (s), 123.8 (s) 128.9 (d), 129.1 (d),
129.3 (d), 131.6 (d), 138.3 (s), 138.8 (s) 155.1 (s), 156.9
(s). MS: m/z 412 (M+). Anal. Calcd for C23H28N2O5:
C, 66.97; H, 6.84; N, 6.79. Found: C, 67.25; H, 7.14; N,
6.57.
1H NMR (400 MHz, CDCl3) d: 1.32 (3H, t, J = 7.1 Hz),
2.49 (1H, br s, missing after deuteriation), 2.90–2.94 (1H,
m), 3.13 (1H, dd, J = 5.1, 13.5 Hz), 3.63 (1H, dd, J = 4.7,
10.5 Hz), 3.82 (1H, d, J = 8.0 Hz), 3.87 (1H, d,
J = 8.9 Hz), 3.92 (1H, dd, J = 4.7, 9.9 Hz), 4.06 (1H, dd,
J = 9.9, 10.5 Hz), 4.14 (1H, dd, J = 8.4, 8.9 Hz), 4.16
(1H, dd, J = 2.2, 13.5 Hz), 4.25 (1H, dq, J = 7.1,
10.0 Hz), 4.29 (1H, dq, J = 7.1, 10.0 Hz), 5.99 (2H, s),
6.68 (1H, s), 6.99 (1H, s), 7.35–7.41 (3H, overlapping),
7.45–7.48 (2H, overlapping); 13C NMR (100 MHz, CDCl3)
d: 15.0 (q), 46.2 (d), 47.3 (t), 61.4 (d), 62.5 (t), 64.0 (t), 67.3
(d), 70.2 (t), 101.9 (t), 107.3 (d), 109.4 (d), 122.1 (s) 128.6
(d), 128.7 (d), 130.7 (d), 135.6 (s), 135.7 (s), 145.4 (s)
147.8 (s), 155.6 (s). MS: m/z 412 (M+). Anal. Calcd for